• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC EUROPE SARL EVERA MRI XT DR SURESCAN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC EUROPE SARL EVERA MRI XT DR SURESCAN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER Back to Search Results
Model Number DDMB1D4
Device Problems Signal Artifact/Noise (1036); Mechanical Problem (1384); Over-Sensing (1438); Capturing Problem (2891); Impedance Problem (2950); High Capture Threshold (3266)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/14/2023
Event Type  Injury  
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
It was reported that after the patient received appropriate therapy last year, the right ventricular (rv) lead impedances and capture thresholds were gradually trending upward.A lead alert had later triggered due to rv impedance variation and short v-v intervals.High capture thresholds were also noted.The rv lead polarity configuration was reprogrammed, and it was further noted that short v-v intervals were accumulating more frequently.There were non-sustained ventricular tachycardia (nsvt) episodes showing non-physiologic noise, however, isometric testing could not reproduce the noise.It was further reported that during a revision procedure, the physician pulled on the rv lead, and it came directly out of the implantable cardioverter defibrillator (icd).The decision was made to remove and replace icd due to the uncertainty of the set screw.The rv lead remains in use.No patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Correction: additional codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Product event summary: the device was not returned for analysis, however, performance data collected from the device was received and analyzed.Analysis of the device memory indicated the impedance trend of the right ventricular pacing lead was rising.Analysis of the device memory indicated the impedance trend of the right ventricular defibrillation coil was rising.Analysis of the device memory indicated the impedance trend of the right ventricular defibrillation coil was variable.Analysis of the device memory indicated the impedance trend of the right ventricular pacing lead was variable.Analysis of the device memory indicated pacing capture threshold in the right ventricle was elevated.Analysis of the device memory indicated pacing capture threshold in the right ventricle was rising.Analysis of the device memory indicated noise.Analysis of the device memory indicated oversensing due to non-physiologic signals/sensing integrity counter.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERA MRI XT DR SURESCAN
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER
Manufacturer (Section D)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ  1131
Manufacturer (Section G)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ   1131
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key19168362
MDR Text Key340873778
Report Number9614453-2024-01596
Device Sequence Number1
Product Code LWS
UDI-Device Identifier00763000059491
UDI-Public00763000059491
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P980016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 05/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/14/2024
Device Model NumberDDMB1D4
Device Catalogue NumberDDMB1D4
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/01/2024
Initial Date FDA Received04/23/2024
Supplement Dates Manufacturer Received04/23/2024
04/26/2024
Supplement Dates FDA Received04/23/2024
05/13/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6935M62 LEAD, 507652 LEAD
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age68 YR
Patient SexFemale
-
-